Shuren, who retired from his spot leading the FDA’s Center for Devices and Radiological Health (CDRH) in 2024, said last week ...

Duality Biologics has begun (PDF) offering stock, wading into a market reeling from Presid | Duality Biologics has begun ...

U.K.-based Epsilogen has bought Boston biotech TigaTx with the aim of creating “the world’s leading pan-isotype cancer ...

As scientists across the U.S. face increasing uncertainty due to funding freezes and mass layoffs at health agencies, German ...

Lexeo Therapeutics has posted updated data in Friedreich ataxia (FA) patients, linking a gene therapy to improvements on ...

J&J’s new pivotal study in coronary artery disease, dubbed FORWARD CAD, will test a cardiac-focused version of the Javelin as ...

| Facing “build versus buy,” or “rent versus own” for integration? Get a guide to the considerations for your organization’s ...

GSK has continued to flesh out its neuroscience strategy with a 2 billion pound sterling ($2.5 billion) deal to use a South ...

Just after PureTech Health confirmed it was in talks with Nordic Capital regarding a possible buyout, Nordic quickly set the record straight with its own announcement that it does not intend to mak | ...

NashBio, a pioneer in genomics and real-world data, is transforming life sciences research by making complex healthcare data more accessible. | NashBio is transforming life sciences by making complex ...

Sangamo Therapeutics has stacked up $18 million cash from Eli Lilly in a licensing deal that will let the pharma use the ...

The cuts impact more than $2.4 billion in grant money, including $1.3 billion in grant funds already spent on projects ...